Acadia Pharmaceutica (NASDAQ:ACAD).
Senator Investment Group LP reports that it lowered its stake in Acadia Pharmaceutica by 556,262 shares in its quarterly SEC filing. Its investment stood at $54,386,000 a decrease of 2.5% as of quarter end.
The following firms have recently changed their position in ACAD. Schwab Charles Investment Management Inc grew its position by buying 33,478 shares an increase of 8.6% in the quarter. Schwab Charles Investment Management Inc controls 422,605 shares valued at $15,920,000. The total value of its holdings increased 46.7%. As of the end of the quarter Tiaa Cref Investment Management LLC had acquired a total of 518,365 shares growing its stake by 175.8%. The value of the investment in ACAD increased from $8,226,000 to $30,637,000 a change of $22,411,000 since the last quarter.
Sectoral Asset Management Inc divested its holdings by selling 276,417 shares a decrease of 25.2% as of 09/30/2017. Sectoral Asset Management Inc now holds 822,392 shares worth $30,980,000. The value of the position overall is up by 1.1%.
On November 8 HC Wainwright held the company rating at “Buy” targeting a price of $60.00. November 7 investment analysts at Cowen and Company left the stock rating at “Buy” with a current price target of $46.00.
October 12 investment analysts at Jefferies Group LLC kept the stock rating at “Buy” projecting a price of $47.00. On October 9, 2017 Leerink Swann maintained a “Market Perform” rating on the company.
October 6 investment analysts at Goldman Sachs Group, Inc. (The) held the stock rating at “Neutral” with a current price target of $45.00. On October 5, 2017 J P Morgan Chase & Co released research on ACAD and giving a rating of “Buy” and establishing a price target of $50.00.
The company is up since yesterday’s close of 26.84. The P/E ratio is currently N/A and the market value is 3.32B. As of the latest earnings report the EPS was $-2.46 with 124.21M shares currently outstanding.
Traders are a little more bearish on Acadia Pharmaceutica of late as evidenced by the change in short interest. The firm experienced a rise in short interest between September 29, 2017 and October 13, 2017 of 3.58%. Short interest grew 233,319 over that period. Days to cover decreased from 6.0 to 4.0 and the short interest percentage is 0.05% as of October 13.